Brain Tumor Drug Development: Current Advances and Strategies (Part 2)
Abstract
Brain Tumor Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumors. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care.
Key Features
Discusses how to overcome the blood-brain barrier using advanced delivery methods
Explains how to improve drug penetration and specificity with nano and polymer-based systems
Explores new therapies through immunotherapy, gene therapy, and personalised medicine
Outlines preclinical models and identifies biomarkers to support clinical success
Details regulatory-aligned clinical trial strategies for faster translation